Global Cannabinoid Drugs Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect
The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Cannabinoid Drugs market covering all its essential aspects.
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global Cannabinoid Drugs market are covered in Chapter 9:
Cannabics Pharmaceuticals Inc.
Zynerba Pharmaceuticals
Indevus Pharmaceuticals
Teewinot Life Sciences
MedReleaf Australia
Cyrelian Pty Ltd.
Valeant Pharmaceuticals International
GW Pharmaceuticals
Abbott Laboratories
AusCann Group Holdings Pty Ltd.
Enecta
Cape Bouvard Technologies Pty Ltd
Tilray
GD Pharma
Alpha-CAT
In Chapter 5 and Chapter 7.3, based on types, the Cannabinoid Drugs market from 2017 to 2027 is primarily split into:
Phytocannabinoids
Endocannabinoids
Synthetics
In Chapter 6 and Chapter 7.4, based on applications, the Cannabinoid Drugs market from 2017 to 2027 covers:
Hospitals
Clinics
Ambulatory Surgical Centers
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Cannabinoid Drugs market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Cannabinoid Drugs Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global Cannabinoid Drugs market are covered in Chapter 9:
Cannabics Pharmaceuticals Inc.
Zynerba Pharmaceuticals
Indevus Pharmaceuticals
Teewinot Life Sciences
MedReleaf Australia
Cyrelian Pty Ltd.
Valeant Pharmaceuticals International
GW Pharmaceuticals
Abbott Laboratories
AusCann Group Holdings Pty Ltd.
Enecta
Cape Bouvard Technologies Pty Ltd
Tilray
GD Pharma
Alpha-CAT
In Chapter 5 and Chapter 7.3, based on types, the Cannabinoid Drugs market from 2017 to 2027 is primarily split into:
Phytocannabinoids
Endocannabinoids
Synthetics
In Chapter 6 and Chapter 7.4, based on applications, the Cannabinoid Drugs market from 2017 to 2027 covers:
Hospitals
Clinics
Ambulatory Surgical Centers
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Cannabinoid Drugs market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Cannabinoid Drugs Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
1 CANNABINOID DRUGS MARKET OVERVIEW
1.1 Product Overview and Scope of Cannabinoid Drugs Market
1.2 Cannabinoid Drugs Market Segment by Type
1.2.1 Global Cannabinoid Drugs Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Cannabinoid Drugs Market Segment by Application
1.3.1 Cannabinoid Drugs Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Cannabinoid Drugs Market, Region Wise (2017-2027)
1.4.1 Global Cannabinoid Drugs Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Cannabinoid Drugs Market Status and Prospect (2017-2027)
1.4.3 Europe Cannabinoid Drugs Market Status and Prospect (2017-2027)
1.4.4 China Cannabinoid Drugs Market Status and Prospect (2017-2027)
1.4.5 Japan Cannabinoid Drugs Market Status and Prospect (2017-2027)
1.4.6 India Cannabinoid Drugs Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Cannabinoid Drugs Market Status and Prospect (2017-2027)
1.4.8 Latin America Cannabinoid Drugs Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Cannabinoid Drugs Market Status and Prospect (2017-2027)
1.5 Global Market Size of Cannabinoid Drugs (2017-2027)
1.5.1 Global Cannabinoid Drugs Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Cannabinoid Drugs Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Cannabinoid Drugs Market
2 INDUSTRY OUTLOOK
2.1 Cannabinoid Drugs Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Cannabinoid Drugs Market Drivers Analysis
2.4 Cannabinoid Drugs Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Cannabinoid Drugs Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Cannabinoid Drugs Industry Development
3 GLOBAL CANNABINOID DRUGS MARKET LANDSCAPE BY PLAYER
3.1 Global Cannabinoid Drugs Sales Volume and Share by Player (2017-2022)
3.2 Global Cannabinoid Drugs Revenue and Market Share by Player (2017-2022)
3.3 Global Cannabinoid Drugs Average Price by Player (2017-2022)
3.4 Global Cannabinoid Drugs Gross Margin by Player (2017-2022)
3.5 Cannabinoid Drugs Market Competitive Situation and Trends
3.5.1 Cannabinoid Drugs Market Concentration Rate
3.5.2 Cannabinoid Drugs Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL CANNABINOID DRUGS SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Cannabinoid Drugs Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Cannabinoid Drugs Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Cannabinoid Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Cannabinoid Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Cannabinoid Drugs Market Under COVID-19
4.5 Europe Cannabinoid Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Cannabinoid Drugs Market Under COVID-19
4.6 China Cannabinoid Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Cannabinoid Drugs Market Under COVID-19
4.7 Japan Cannabinoid Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Cannabinoid Drugs Market Under COVID-19
4.8 India Cannabinoid Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Cannabinoid Drugs Market Under COVID-19
4.9 Southeast Asia Cannabinoid Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Cannabinoid Drugs Market Under COVID-19
4.10 Latin America Cannabinoid Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Cannabinoid Drugs Market Under COVID-19
4.11 Middle East and Africa Cannabinoid Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Cannabinoid Drugs Market Under COVID-19
5 GLOBAL CANNABINOID DRUGS SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Cannabinoid Drugs Sales Volume and Market Share by Type (2017-2022)
5.2 Global Cannabinoid Drugs Revenue and Market Share by Type (2017-2022)
5.3 Global Cannabinoid Drugs Price by Type (2017-2022)
5.4 Global Cannabinoid Drugs Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Cannabinoid Drugs Sales Volume, Revenue and Growth Rate of Phytocannabinoids (2017-2022)
5.4.2 Global Cannabinoid Drugs Sales Volume, Revenue and Growth Rate of Endocannabinoids (2017-2022)
5.4.3 Global Cannabinoid Drugs Sales Volume, Revenue and Growth Rate of Synthetics (2017-2022)
6 GLOBAL CANNABINOID DRUGS MARKET ANALYSIS BY APPLICATION
6.1 Global Cannabinoid Drugs Consumption and Market Share by Application (2017-2022)
6.2 Global Cannabinoid Drugs Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Cannabinoid Drugs Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Cannabinoid Drugs Consumption and Growth Rate of Hospitals (2017-2022)
6.3.2 Global Cannabinoid Drugs Consumption and Growth Rate of Clinics (2017-2022)
6.3.3 Global Cannabinoid Drugs Consumption and Growth Rate of Ambulatory Surgical Centers (2017-2022)
6.3.4 Global Cannabinoid Drugs Consumption and Growth Rate of Others (2017-2022)
7 GLOBAL CANNABINOID DRUGS MARKET FORECAST (2022-2027)
7.1 Global Cannabinoid Drugs Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Cannabinoid Drugs Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Cannabinoid Drugs Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Cannabinoid Drugs Price and Trend Forecast (2022-2027)
7.2 Global Cannabinoid Drugs Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Cannabinoid Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Cannabinoid Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Cannabinoid Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Cannabinoid Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Cannabinoid Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Cannabinoid Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Cannabinoid Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Cannabinoid Drugs Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Cannabinoid Drugs Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Cannabinoid Drugs Revenue and Growth Rate of Phytocannabinoids (2022-2027)
7.3.2 Global Cannabinoid Drugs Revenue and Growth Rate of Endocannabinoids (2022-2027)
7.3.3 Global Cannabinoid Drugs Revenue and Growth Rate of Synthetics (2022-2027)
7.4 Global Cannabinoid Drugs Consumption Forecast by Application (2022-2027)
7.4.1 Global Cannabinoid Drugs Consumption Value and Growth Rate of Hospitals(2022-2027)
7.4.2 Global Cannabinoid Drugs Consumption Value and Growth Rate of Clinics(2022-2027)
7.4.3 Global Cannabinoid Drugs Consumption Value and Growth Rate of Ambulatory Surgical Centers(2022-2027)
7.4.4 Global Cannabinoid Drugs Consumption Value and Growth Rate of Others(2022-2027)
7.5 Cannabinoid Drugs Market Forecast Under COVID-19
8 CANNABINOID DRUGS MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Cannabinoid Drugs Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Cannabinoid Drugs Analysis
8.6 Major Downstream Buyers of Cannabinoid Drugs Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Cannabinoid Drugs Industry
9 PLAYERS PROFILES
9.1 Cannabics Pharmaceuticals Inc.
9.1.1 Cannabics Pharmaceuticals Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Cannabinoid Drugs Product Profiles, Application and Specification
9.1.3 Cannabics Pharmaceuticals Inc. Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Zynerba Pharmaceuticals
9.2.1 Zynerba Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Cannabinoid Drugs Product Profiles, Application and Specification
9.2.3 Zynerba Pharmaceuticals Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Indevus Pharmaceuticals
9.3.1 Indevus Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Cannabinoid Drugs Product Profiles, Application and Specification
9.3.3 Indevus Pharmaceuticals Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Teewinot Life Sciences
9.4.1 Teewinot Life Sciences Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Cannabinoid Drugs Product Profiles, Application and Specification
9.4.3 Teewinot Life Sciences Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 MedReleaf Australia
9.5.1 MedReleaf Australia Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Cannabinoid Drugs Product Profiles, Application and Specification
9.5.3 MedReleaf Australia Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Cyrelian Pty Ltd.
9.6.1 Cyrelian Pty Ltd. Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Cannabinoid Drugs Product Profiles, Application and Specification
9.6.3 Cyrelian Pty Ltd. Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Valeant Pharmaceuticals International
9.7.1 Valeant Pharmaceuticals International Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Cannabinoid Drugs Product Profiles, Application and Specification
9.7.3 Valeant Pharmaceuticals International Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 GW Pharmaceuticals
9.8.1 GW Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Cannabinoid Drugs Product Profiles, Application and Specification
9.8.3 GW Pharmaceuticals Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 Abbott Laboratories
9.9.1 Abbott Laboratories Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Cannabinoid Drugs Product Profiles, Application and Specification
9.9.3 Abbott Laboratories Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 AusCann Group Holdings Pty Ltd.
9.10.1 AusCann Group Holdings Pty Ltd. Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Cannabinoid Drugs Product Profiles, Application and Specification
9.10.3 AusCann Group Holdings Pty Ltd. Market Performance (2017-2022)
9.10.4 Recent Development
9.10.5 SWOT Analysis
9.11 Enecta
9.11.1 Enecta Basic Information, Manufacturing Base, Sales Region and Competitors
9.11.2 Cannabinoid Drugs Product Profiles, Application and Specification
9.11.3 Enecta Market Performance (2017-2022)
9.11.4 Recent Development
9.11.5 SWOT Analysis
9.12 Cape Bouvard Technologies Pty Ltd
9.12.1 Cape Bouvard Technologies Pty Ltd Basic Information, Manufacturing Base, Sales Region and Competitors
9.12.2 Cannabinoid Drugs Product Profiles, Application and Specification
9.12.3 Cape Bouvard Technologies Pty Ltd Market Performance (2017-2022)
9.12.4 Recent Development
9.12.5 SWOT Analysis
9.13 Tilray
9.13.1 Tilray Basic Information, Manufacturing Base, Sales Region and Competitors
9.13.2 Cannabinoid Drugs Product Profiles, Application and Specification
9.13.3 Tilray Market Performance (2017-2022)
9.13.4 Recent Development
9.13.5 SWOT Analysis
9.14 GD Pharma
9.14.1 GD Pharma Basic Information, Manufacturing Base, Sales Region and Competitors
9.14.2 Cannabinoid Drugs Product Profiles, Application and Specification
9.14.3 GD Pharma Market Performance (2017-2022)
9.14.4 Recent Development
9.14.5 SWOT Analysis
9.15 Alpha-CAT
9.15.1 Alpha-CAT Basic Information, Manufacturing Base, Sales Region and Competitors
9.15.2 Cannabinoid Drugs Product Profiles, Application and Specification
9.15.3 Alpha-CAT Market Performance (2017-2022)
9.15.4 Recent Development
9.15.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
1.1 Product Overview and Scope of Cannabinoid Drugs Market
1.2 Cannabinoid Drugs Market Segment by Type
1.2.1 Global Cannabinoid Drugs Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Cannabinoid Drugs Market Segment by Application
1.3.1 Cannabinoid Drugs Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Cannabinoid Drugs Market, Region Wise (2017-2027)
1.4.1 Global Cannabinoid Drugs Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Cannabinoid Drugs Market Status and Prospect (2017-2027)
1.4.3 Europe Cannabinoid Drugs Market Status and Prospect (2017-2027)
1.4.4 China Cannabinoid Drugs Market Status and Prospect (2017-2027)
1.4.5 Japan Cannabinoid Drugs Market Status and Prospect (2017-2027)
1.4.6 India Cannabinoid Drugs Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Cannabinoid Drugs Market Status and Prospect (2017-2027)
1.4.8 Latin America Cannabinoid Drugs Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Cannabinoid Drugs Market Status and Prospect (2017-2027)
1.5 Global Market Size of Cannabinoid Drugs (2017-2027)
1.5.1 Global Cannabinoid Drugs Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Cannabinoid Drugs Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Cannabinoid Drugs Market
2 INDUSTRY OUTLOOK
2.1 Cannabinoid Drugs Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Cannabinoid Drugs Market Drivers Analysis
2.4 Cannabinoid Drugs Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Cannabinoid Drugs Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Cannabinoid Drugs Industry Development
3 GLOBAL CANNABINOID DRUGS MARKET LANDSCAPE BY PLAYER
3.1 Global Cannabinoid Drugs Sales Volume and Share by Player (2017-2022)
3.2 Global Cannabinoid Drugs Revenue and Market Share by Player (2017-2022)
3.3 Global Cannabinoid Drugs Average Price by Player (2017-2022)
3.4 Global Cannabinoid Drugs Gross Margin by Player (2017-2022)
3.5 Cannabinoid Drugs Market Competitive Situation and Trends
3.5.1 Cannabinoid Drugs Market Concentration Rate
3.5.2 Cannabinoid Drugs Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL CANNABINOID DRUGS SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Cannabinoid Drugs Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Cannabinoid Drugs Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Cannabinoid Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Cannabinoid Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Cannabinoid Drugs Market Under COVID-19
4.5 Europe Cannabinoid Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Cannabinoid Drugs Market Under COVID-19
4.6 China Cannabinoid Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Cannabinoid Drugs Market Under COVID-19
4.7 Japan Cannabinoid Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Cannabinoid Drugs Market Under COVID-19
4.8 India Cannabinoid Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Cannabinoid Drugs Market Under COVID-19
4.9 Southeast Asia Cannabinoid Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Cannabinoid Drugs Market Under COVID-19
4.10 Latin America Cannabinoid Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Cannabinoid Drugs Market Under COVID-19
4.11 Middle East and Africa Cannabinoid Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Cannabinoid Drugs Market Under COVID-19
5 GLOBAL CANNABINOID DRUGS SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Cannabinoid Drugs Sales Volume and Market Share by Type (2017-2022)
5.2 Global Cannabinoid Drugs Revenue and Market Share by Type (2017-2022)
5.3 Global Cannabinoid Drugs Price by Type (2017-2022)
5.4 Global Cannabinoid Drugs Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Cannabinoid Drugs Sales Volume, Revenue and Growth Rate of Phytocannabinoids (2017-2022)
5.4.2 Global Cannabinoid Drugs Sales Volume, Revenue and Growth Rate of Endocannabinoids (2017-2022)
5.4.3 Global Cannabinoid Drugs Sales Volume, Revenue and Growth Rate of Synthetics (2017-2022)
6 GLOBAL CANNABINOID DRUGS MARKET ANALYSIS BY APPLICATION
6.1 Global Cannabinoid Drugs Consumption and Market Share by Application (2017-2022)
6.2 Global Cannabinoid Drugs Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Cannabinoid Drugs Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Cannabinoid Drugs Consumption and Growth Rate of Hospitals (2017-2022)
6.3.2 Global Cannabinoid Drugs Consumption and Growth Rate of Clinics (2017-2022)
6.3.3 Global Cannabinoid Drugs Consumption and Growth Rate of Ambulatory Surgical Centers (2017-2022)
6.3.4 Global Cannabinoid Drugs Consumption and Growth Rate of Others (2017-2022)
7 GLOBAL CANNABINOID DRUGS MARKET FORECAST (2022-2027)
7.1 Global Cannabinoid Drugs Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Cannabinoid Drugs Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Cannabinoid Drugs Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Cannabinoid Drugs Price and Trend Forecast (2022-2027)
7.2 Global Cannabinoid Drugs Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Cannabinoid Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Cannabinoid Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Cannabinoid Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Cannabinoid Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Cannabinoid Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Cannabinoid Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Cannabinoid Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Cannabinoid Drugs Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Cannabinoid Drugs Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Cannabinoid Drugs Revenue and Growth Rate of Phytocannabinoids (2022-2027)
7.3.2 Global Cannabinoid Drugs Revenue and Growth Rate of Endocannabinoids (2022-2027)
7.3.3 Global Cannabinoid Drugs Revenue and Growth Rate of Synthetics (2022-2027)
7.4 Global Cannabinoid Drugs Consumption Forecast by Application (2022-2027)
7.4.1 Global Cannabinoid Drugs Consumption Value and Growth Rate of Hospitals(2022-2027)
7.4.2 Global Cannabinoid Drugs Consumption Value and Growth Rate of Clinics(2022-2027)
7.4.3 Global Cannabinoid Drugs Consumption Value and Growth Rate of Ambulatory Surgical Centers(2022-2027)
7.4.4 Global Cannabinoid Drugs Consumption Value and Growth Rate of Others(2022-2027)
7.5 Cannabinoid Drugs Market Forecast Under COVID-19
8 CANNABINOID DRUGS MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Cannabinoid Drugs Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Cannabinoid Drugs Analysis
8.6 Major Downstream Buyers of Cannabinoid Drugs Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Cannabinoid Drugs Industry
9 PLAYERS PROFILES
9.1 Cannabics Pharmaceuticals Inc.
9.1.1 Cannabics Pharmaceuticals Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Cannabinoid Drugs Product Profiles, Application and Specification
9.1.3 Cannabics Pharmaceuticals Inc. Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Zynerba Pharmaceuticals
9.2.1 Zynerba Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Cannabinoid Drugs Product Profiles, Application and Specification
9.2.3 Zynerba Pharmaceuticals Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Indevus Pharmaceuticals
9.3.1 Indevus Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Cannabinoid Drugs Product Profiles, Application and Specification
9.3.3 Indevus Pharmaceuticals Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Teewinot Life Sciences
9.4.1 Teewinot Life Sciences Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Cannabinoid Drugs Product Profiles, Application and Specification
9.4.3 Teewinot Life Sciences Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 MedReleaf Australia
9.5.1 MedReleaf Australia Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Cannabinoid Drugs Product Profiles, Application and Specification
9.5.3 MedReleaf Australia Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Cyrelian Pty Ltd.
9.6.1 Cyrelian Pty Ltd. Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Cannabinoid Drugs Product Profiles, Application and Specification
9.6.3 Cyrelian Pty Ltd. Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Valeant Pharmaceuticals International
9.7.1 Valeant Pharmaceuticals International Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Cannabinoid Drugs Product Profiles, Application and Specification
9.7.3 Valeant Pharmaceuticals International Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 GW Pharmaceuticals
9.8.1 GW Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Cannabinoid Drugs Product Profiles, Application and Specification
9.8.3 GW Pharmaceuticals Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 Abbott Laboratories
9.9.1 Abbott Laboratories Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Cannabinoid Drugs Product Profiles, Application and Specification
9.9.3 Abbott Laboratories Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 AusCann Group Holdings Pty Ltd.
9.10.1 AusCann Group Holdings Pty Ltd. Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Cannabinoid Drugs Product Profiles, Application and Specification
9.10.3 AusCann Group Holdings Pty Ltd. Market Performance (2017-2022)
9.10.4 Recent Development
9.10.5 SWOT Analysis
9.11 Enecta
9.11.1 Enecta Basic Information, Manufacturing Base, Sales Region and Competitors
9.11.2 Cannabinoid Drugs Product Profiles, Application and Specification
9.11.3 Enecta Market Performance (2017-2022)
9.11.4 Recent Development
9.11.5 SWOT Analysis
9.12 Cape Bouvard Technologies Pty Ltd
9.12.1 Cape Bouvard Technologies Pty Ltd Basic Information, Manufacturing Base, Sales Region and Competitors
9.12.2 Cannabinoid Drugs Product Profiles, Application and Specification
9.12.3 Cape Bouvard Technologies Pty Ltd Market Performance (2017-2022)
9.12.4 Recent Development
9.12.5 SWOT Analysis
9.13 Tilray
9.13.1 Tilray Basic Information, Manufacturing Base, Sales Region and Competitors
9.13.2 Cannabinoid Drugs Product Profiles, Application and Specification
9.13.3 Tilray Market Performance (2017-2022)
9.13.4 Recent Development
9.13.5 SWOT Analysis
9.14 GD Pharma
9.14.1 GD Pharma Basic Information, Manufacturing Base, Sales Region and Competitors
9.14.2 Cannabinoid Drugs Product Profiles, Application and Specification
9.14.3 GD Pharma Market Performance (2017-2022)
9.14.4 Recent Development
9.14.5 SWOT Analysis
9.15 Alpha-CAT
9.15.1 Alpha-CAT Basic Information, Manufacturing Base, Sales Region and Competitors
9.15.2 Cannabinoid Drugs Product Profiles, Application and Specification
9.15.3 Alpha-CAT Market Performance (2017-2022)
9.15.4 Recent Development
9.15.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
LIST OF TABLES AND FIGURES
Figure Cannabinoid Drugs Product Picture
Table Global Cannabinoid Drugs Market Sales Volume and CAGR (%) Comparison by Type
Table Cannabinoid Drugs Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Cannabinoid Drugs Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Cannabinoid Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Cannabinoid Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Cannabinoid Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Cannabinoid Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Cannabinoid Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Cannabinoid Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Cannabinoid Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Cannabinoid Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Cannabinoid Drugs Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Cannabinoid Drugs Industry Development
Table Global Cannabinoid Drugs Sales Volume by Player (2017-2022)
Table Global Cannabinoid Drugs Sales Volume Share by Player (2017-2022)
Figure Global Cannabinoid Drugs Sales Volume Share by Player in 2021
Table Cannabinoid Drugs Revenue (Million USD) by Player (2017-2022)
Table Cannabinoid Drugs Revenue Market Share by Player (2017-2022)
Table Cannabinoid Drugs Price by Player (2017-2022)
Table Cannabinoid Drugs Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Cannabinoid Drugs Sales Volume, Region Wise (2017-2022)
Table Global Cannabinoid Drugs Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Cannabinoid Drugs Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Cannabinoid Drugs Sales Volume Market Share, Region Wise in 2021
Table Global Cannabinoid Drugs Revenue (Million USD), Region Wise (2017-2022)
Table Global Cannabinoid Drugs Revenue Market Share, Region Wise (2017-2022)
Figure Global Cannabinoid Drugs Revenue Market Share, Region Wise (2017-2022)
Figure Global Cannabinoid Drugs Revenue Market Share, Region Wise in 2021
Table Global Cannabinoid Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Cannabinoid Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Cannabinoid Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Cannabinoid Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Cannabinoid Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Cannabinoid Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Cannabinoid Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Cannabinoid Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Cannabinoid Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Cannabinoid Drugs Sales Volume by Type (2017-2022)
Table Global Cannabinoid Drugs Sales Volume Market Share by Type (2017-2022)
Figure Global Cannabinoid Drugs Sales Volume Market Share by Type in 2021
Table Global Cannabinoid Drugs Revenue (Million USD) by Type (2017-2022)
Table Global Cannabinoid Drugs Revenue Market Share by Type (2017-2022)
Figure Global Cannabinoid Drugs Revenue Market Share by Type in 2021
Table Cannabinoid Drugs Price by Type (2017-2022)
Figure Global Cannabinoid Drugs Sales Volume and Growth Rate of Phytocannabinoids (2017-2022)
Figure Global Cannabinoid Drugs Revenue (Million USD) and Growth Rate of Phytocannabinoids (2017-2022)
Figure Global Cannabinoid Drugs Sales Volume and Growth Rate of Endocannabinoids (2017-2022)
Figure Global Cannabinoid Drugs Revenue (Million USD) and Growth Rate of Endocannabinoids (2017-2022)
Figure Global Cannabinoid Drugs Sales Volume and Growth Rate of Synthetics (2017-2022)
Figure Global Cannabinoid Drugs Revenue (Million USD) and Growth Rate of Synthetics (2017-2022)
Table Global Cannabinoid Drugs Consumption by Application (2017-2022)
Table Global Cannabinoid Drugs Consumption Market Share by Application (2017-2022)
Table Global Cannabinoid Drugs Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Cannabinoid Drugs Consumption Revenue Market Share by Application (2017-2022)
Table Global Cannabinoid Drugs Consumption and Growth Rate of Hospitals (2017-2022)
Table Global Cannabinoid Drugs Consumption and Growth Rate of Clinics (2017-2022)
Table Global Cannabinoid Drugs Consumption and Growth Rate of Ambulatory Surgical Centers (2017-2022)
Table Global Cannabinoid Drugs Consumption and Growth Rate of Others (2017-2022)
Figure Global Cannabinoid Drugs Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Cannabinoid Drugs Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Cannabinoid Drugs Price and Trend Forecast (2022-2027)
Figure USA Cannabinoid Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Cannabinoid Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Cannabinoid Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Cannabinoid Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Cannabinoid Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Cannabinoid Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Cannabinoid Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Cannabinoid Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Cannabinoid Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Cannabinoid Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Cannabinoid Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Cannabinoid Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Cannabinoid Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Cannabinoid Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Cannabinoid Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Cannabinoid Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Cannabinoid Drugs Market Sales Volume Forecast, by Type
Table Global Cannabinoid Drugs Sales Volume Market Share Forecast, by Type
Table Global Cannabinoid Drugs Market Revenue (Million USD) Forecast, by Type
Table Global Cannabinoid Drugs Revenue Market Share Forecast, by Type
Table Global Cannabinoid Drugs Price Forecast, by Type
Figure Global Cannabinoid Drugs Revenue (Million USD) and Growth Rate of Phytocannabinoids (2022-2027)
Figure Global Cannabinoid Drugs Revenue (Million USD) and Growth Rate of Phytocannabinoids (2022-2027)
Figure Global Cannabinoid Drugs Revenue (Million USD) and Growth Rate of Endocannabinoids (2022-2027)
Figure Global Cannabinoid Drugs Revenue (Million USD) and Growth Rate of Endocannabinoids (2022-2027)
Figure Global Cannabinoid Drugs Revenue (Million USD) and Growth Rate of Synthetics (2022-2027)
Figure Global Cannabinoid Drugs Revenue (Million USD) and Growth Rate of Synthetics (2022-2027)
Table Global Cannabinoid Drugs Market Consumption Forecast, by Application
Table Global Cannabinoid Drugs Consumption Market Share Forecast, by Application
Table Global Cannabinoid Drugs Market Revenue (Million USD) Forecast, by Application
Table Global Cannabinoid Drugs Revenue Market Share Forecast, by Application
Figure Global Cannabinoid Drugs Consumption Value (Million USD) and Growth Rate of Hospitals (2022-2027)
Figure Global Cannabinoid Drugs Consumption Value (Million USD) and Growth Rate of Clinics (2022-2027)
Figure Global Cannabinoid Drugs Consumption Value (Million USD) and Growth Rate of Ambulatory Surgical Centers (2022-2027)
Figure Global Cannabinoid Drugs Consumption Value (Million USD) and Growth Rate of Others (2022-2027)
Figure Cannabinoid Drugs Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Cannabics Pharmaceuticals Inc. Profile
Table Cannabics Pharmaceuticals Inc. Cannabinoid Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Cannabics Pharmaceuticals Inc. Cannabinoid Drugs Sales Volume and Growth Rate
Figure Cannabics Pharmaceuticals Inc. Revenue (Million USD) Market Share 2017-2022
Table Zynerba Pharmaceuticals Profile
Table Zynerba Pharmaceuticals Cannabinoid Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Zynerba Pharmaceuticals Cannabinoid Drugs Sales Volume and Growth Rate
Figure Zynerba Pharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table Indevus Pharmaceuticals Profile
Table Indevus Pharmaceuticals Cannabinoid Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Indevus Pharmaceuticals Cannabinoid Drugs Sales Volume and Growth Rate
Figure Indevus Pharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table Teewinot Life Sciences Profile
Table Teewinot Life Sciences Cannabinoid Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Teewinot Life Sciences Cannabinoid Drugs Sales Volume and Growth Rate
Figure Teewinot Life Sciences Revenue (Million USD) Market Share 2017-2022
Table MedReleaf Australia Profile
Table MedReleaf Australia Cannabinoid Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure MedReleaf Australia Cannabinoid Drugs Sales Volume and Growth Rate
Figure MedReleaf Australia Revenue (Million USD) Market Share 2017-2022
Table Cyrelian Pty Ltd. Profile
Table Cyrelian Pty Ltd. Cannabinoid Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Cyrelian Pty Ltd. Cannabinoid Drugs Sales Volume and Growth Rate
Figure Cyrelian Pty Ltd. Revenue (Million USD) Market Share 2017-2022
Table Valeant Pharmaceuticals International Profile
Table Valeant Pharmaceuticals International Cannabinoid Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Valeant Pharmaceuticals International Cannabinoid Drugs Sales Volume and Growth Rate
Figure Valeant Pharmaceuticals International Revenue (Million USD) Market Share 2017-2022
Table GW Pharmaceuticals Profile
Table GW Pharmaceuticals Cannabinoid Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure GW Pharmaceuticals Cannabinoid Drugs Sales Volume and Growth Rate
Figure GW Pharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table Abbott Laboratories Profile
Table Abbott Laboratories Cannabinoid Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Abbott Laboratories Cannabinoid Drugs Sales Volume and Growth Rate
Figure Abbott Laboratories Revenue (Million USD) Market Share 2017-2022
Table AusCann Group Holdings Pty Ltd. Profile
Table AusCann Group Holdings Pty Ltd. Cannabinoid Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure AusCann Group Holdings Pty Ltd. Cannabinoid Drugs Sales Volume and Growth Rate
Figure AusCann Group Holdings Pty Ltd. Revenue (Million USD) Market Share 2017-2022
Table Enecta Profile
Table Enecta Cannabinoid Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Enecta Cannabinoid Drugs Sales Volume and Growth Rate
Figure Enecta Revenue (Million USD) Market Share 2017-2022
Table Cape Bouvard Technologies Pty Ltd Profile
Table Cape Bouvard Technologies Pty Ltd Cannabinoid Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Cape Bouvard Technologies Pty Ltd Cannabinoid Drugs Sales Volume and Growth Rate
Figure Cape Bouvard Technologies Pty Ltd Revenue (Million USD) Market Share 2017-2022
Table Tilray Profile
Table Tilray Cannabinoid Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Tilray Cannabinoid Drugs Sales Volume and Growth Rate
Figure Tilray Revenue (Million USD) Market Share 2017-2022
Table GD Pharma Profile
Table GD Pharma Cannabinoid Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure GD Pharma Cannabinoid Drugs Sales Volume and Growth Rate
Figure GD Pharma Revenue (Million USD) Market Share 2017-2022
Table Alpha-CAT Profile
Table Alpha-CAT Cannabinoid Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Alpha-CAT Cannabinoid Drugs Sales Volume and Growth Rate
Figure Alpha-CAT Revenue (Million USD) Market Share 2017-2022
Figure Cannabinoid Drugs Product Picture
Table Global Cannabinoid Drugs Market Sales Volume and CAGR (%) Comparison by Type
Table Cannabinoid Drugs Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Cannabinoid Drugs Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Cannabinoid Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Cannabinoid Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Cannabinoid Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Cannabinoid Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Cannabinoid Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Cannabinoid Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Cannabinoid Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Cannabinoid Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Cannabinoid Drugs Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Cannabinoid Drugs Industry Development
Table Global Cannabinoid Drugs Sales Volume by Player (2017-2022)
Table Global Cannabinoid Drugs Sales Volume Share by Player (2017-2022)
Figure Global Cannabinoid Drugs Sales Volume Share by Player in 2021
Table Cannabinoid Drugs Revenue (Million USD) by Player (2017-2022)
Table Cannabinoid Drugs Revenue Market Share by Player (2017-2022)
Table Cannabinoid Drugs Price by Player (2017-2022)
Table Cannabinoid Drugs Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Cannabinoid Drugs Sales Volume, Region Wise (2017-2022)
Table Global Cannabinoid Drugs Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Cannabinoid Drugs Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Cannabinoid Drugs Sales Volume Market Share, Region Wise in 2021
Table Global Cannabinoid Drugs Revenue (Million USD), Region Wise (2017-2022)
Table Global Cannabinoid Drugs Revenue Market Share, Region Wise (2017-2022)
Figure Global Cannabinoid Drugs Revenue Market Share, Region Wise (2017-2022)
Figure Global Cannabinoid Drugs Revenue Market Share, Region Wise in 2021
Table Global Cannabinoid Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Cannabinoid Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Cannabinoid Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Cannabinoid Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Cannabinoid Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Cannabinoid Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Cannabinoid Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Cannabinoid Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Cannabinoid Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Cannabinoid Drugs Sales Volume by Type (2017-2022)
Table Global Cannabinoid Drugs Sales Volume Market Share by Type (2017-2022)
Figure Global Cannabinoid Drugs Sales Volume Market Share by Type in 2021
Table Global Cannabinoid Drugs Revenue (Million USD) by Type (2017-2022)
Table Global Cannabinoid Drugs Revenue Market Share by Type (2017-2022)
Figure Global Cannabinoid Drugs Revenue Market Share by Type in 2021
Table Cannabinoid Drugs Price by Type (2017-2022)
Figure Global Cannabinoid Drugs Sales Volume and Growth Rate of Phytocannabinoids (2017-2022)
Figure Global Cannabinoid Drugs Revenue (Million USD) and Growth Rate of Phytocannabinoids (2017-2022)
Figure Global Cannabinoid Drugs Sales Volume and Growth Rate of Endocannabinoids (2017-2022)
Figure Global Cannabinoid Drugs Revenue (Million USD) and Growth Rate of Endocannabinoids (2017-2022)
Figure Global Cannabinoid Drugs Sales Volume and Growth Rate of Synthetics (2017-2022)
Figure Global Cannabinoid Drugs Revenue (Million USD) and Growth Rate of Synthetics (2017-2022)
Table Global Cannabinoid Drugs Consumption by Application (2017-2022)
Table Global Cannabinoid Drugs Consumption Market Share by Application (2017-2022)
Table Global Cannabinoid Drugs Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Cannabinoid Drugs Consumption Revenue Market Share by Application (2017-2022)
Table Global Cannabinoid Drugs Consumption and Growth Rate of Hospitals (2017-2022)
Table Global Cannabinoid Drugs Consumption and Growth Rate of Clinics (2017-2022)
Table Global Cannabinoid Drugs Consumption and Growth Rate of Ambulatory Surgical Centers (2017-2022)
Table Global Cannabinoid Drugs Consumption and Growth Rate of Others (2017-2022)
Figure Global Cannabinoid Drugs Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Cannabinoid Drugs Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Cannabinoid Drugs Price and Trend Forecast (2022-2027)
Figure USA Cannabinoid Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Cannabinoid Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Cannabinoid Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Cannabinoid Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Cannabinoid Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Cannabinoid Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Cannabinoid Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Cannabinoid Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Cannabinoid Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Cannabinoid Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Cannabinoid Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Cannabinoid Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Cannabinoid Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Cannabinoid Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Cannabinoid Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Cannabinoid Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Cannabinoid Drugs Market Sales Volume Forecast, by Type
Table Global Cannabinoid Drugs Sales Volume Market Share Forecast, by Type
Table Global Cannabinoid Drugs Market Revenue (Million USD) Forecast, by Type
Table Global Cannabinoid Drugs Revenue Market Share Forecast, by Type
Table Global Cannabinoid Drugs Price Forecast, by Type
Figure Global Cannabinoid Drugs Revenue (Million USD) and Growth Rate of Phytocannabinoids (2022-2027)
Figure Global Cannabinoid Drugs Revenue (Million USD) and Growth Rate of Phytocannabinoids (2022-2027)
Figure Global Cannabinoid Drugs Revenue (Million USD) and Growth Rate of Endocannabinoids (2022-2027)
Figure Global Cannabinoid Drugs Revenue (Million USD) and Growth Rate of Endocannabinoids (2022-2027)
Figure Global Cannabinoid Drugs Revenue (Million USD) and Growth Rate of Synthetics (2022-2027)
Figure Global Cannabinoid Drugs Revenue (Million USD) and Growth Rate of Synthetics (2022-2027)
Table Global Cannabinoid Drugs Market Consumption Forecast, by Application
Table Global Cannabinoid Drugs Consumption Market Share Forecast, by Application
Table Global Cannabinoid Drugs Market Revenue (Million USD) Forecast, by Application
Table Global Cannabinoid Drugs Revenue Market Share Forecast, by Application
Figure Global Cannabinoid Drugs Consumption Value (Million USD) and Growth Rate of Hospitals (2022-2027)
Figure Global Cannabinoid Drugs Consumption Value (Million USD) and Growth Rate of Clinics (2022-2027)
Figure Global Cannabinoid Drugs Consumption Value (Million USD) and Growth Rate of Ambulatory Surgical Centers (2022-2027)
Figure Global Cannabinoid Drugs Consumption Value (Million USD) and Growth Rate of Others (2022-2027)
Figure Cannabinoid Drugs Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Cannabics Pharmaceuticals Inc. Profile
Table Cannabics Pharmaceuticals Inc. Cannabinoid Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Cannabics Pharmaceuticals Inc. Cannabinoid Drugs Sales Volume and Growth Rate
Figure Cannabics Pharmaceuticals Inc. Revenue (Million USD) Market Share 2017-2022
Table Zynerba Pharmaceuticals Profile
Table Zynerba Pharmaceuticals Cannabinoid Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Zynerba Pharmaceuticals Cannabinoid Drugs Sales Volume and Growth Rate
Figure Zynerba Pharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table Indevus Pharmaceuticals Profile
Table Indevus Pharmaceuticals Cannabinoid Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Indevus Pharmaceuticals Cannabinoid Drugs Sales Volume and Growth Rate
Figure Indevus Pharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table Teewinot Life Sciences Profile
Table Teewinot Life Sciences Cannabinoid Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Teewinot Life Sciences Cannabinoid Drugs Sales Volume and Growth Rate
Figure Teewinot Life Sciences Revenue (Million USD) Market Share 2017-2022
Table MedReleaf Australia Profile
Table MedReleaf Australia Cannabinoid Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure MedReleaf Australia Cannabinoid Drugs Sales Volume and Growth Rate
Figure MedReleaf Australia Revenue (Million USD) Market Share 2017-2022
Table Cyrelian Pty Ltd. Profile
Table Cyrelian Pty Ltd. Cannabinoid Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Cyrelian Pty Ltd. Cannabinoid Drugs Sales Volume and Growth Rate
Figure Cyrelian Pty Ltd. Revenue (Million USD) Market Share 2017-2022
Table Valeant Pharmaceuticals International Profile
Table Valeant Pharmaceuticals International Cannabinoid Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Valeant Pharmaceuticals International Cannabinoid Drugs Sales Volume and Growth Rate
Figure Valeant Pharmaceuticals International Revenue (Million USD) Market Share 2017-2022
Table GW Pharmaceuticals Profile
Table GW Pharmaceuticals Cannabinoid Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure GW Pharmaceuticals Cannabinoid Drugs Sales Volume and Growth Rate
Figure GW Pharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table Abbott Laboratories Profile
Table Abbott Laboratories Cannabinoid Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Abbott Laboratories Cannabinoid Drugs Sales Volume and Growth Rate
Figure Abbott Laboratories Revenue (Million USD) Market Share 2017-2022
Table AusCann Group Holdings Pty Ltd. Profile
Table AusCann Group Holdings Pty Ltd. Cannabinoid Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure AusCann Group Holdings Pty Ltd. Cannabinoid Drugs Sales Volume and Growth Rate
Figure AusCann Group Holdings Pty Ltd. Revenue (Million USD) Market Share 2017-2022
Table Enecta Profile
Table Enecta Cannabinoid Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Enecta Cannabinoid Drugs Sales Volume and Growth Rate
Figure Enecta Revenue (Million USD) Market Share 2017-2022
Table Cape Bouvard Technologies Pty Ltd Profile
Table Cape Bouvard Technologies Pty Ltd Cannabinoid Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Cape Bouvard Technologies Pty Ltd Cannabinoid Drugs Sales Volume and Growth Rate
Figure Cape Bouvard Technologies Pty Ltd Revenue (Million USD) Market Share 2017-2022
Table Tilray Profile
Table Tilray Cannabinoid Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Tilray Cannabinoid Drugs Sales Volume and Growth Rate
Figure Tilray Revenue (Million USD) Market Share 2017-2022
Table GD Pharma Profile
Table GD Pharma Cannabinoid Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure GD Pharma Cannabinoid Drugs Sales Volume and Growth Rate
Figure GD Pharma Revenue (Million USD) Market Share 2017-2022
Table Alpha-CAT Profile
Table Alpha-CAT Cannabinoid Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Alpha-CAT Cannabinoid Drugs Sales Volume and Growth Rate
Figure Alpha-CAT Revenue (Million USD) Market Share 2017-2022
